A comparative study of conventional and long-acting formulations of propranolol in essential hypertension.
Hudson
C F
CF
Joseph
S P
SP
Lawrie
D M
DM
Thirkettle
J L
JL
Allsopp
D
D
McAinsh
J
J
D002986:Clinical Trials as Topic; D004304:Dosage Forms; D004311:Double-Blind Method; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors
D004304:Dosage Forms; D011433:Propranolol